Alprazolam and Coma scale abnormal - a phase IV clinical study of FDA data

Summary:

Coma scale abnormal is reported as a side effect among people who take Alprazolam (alprazolam), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Lorazepam, and have Depression.

The phase IV clinical study analyzes which people have Coma scale abnormal when taking Alprazolam. It is created by eHealthMe based on reports of 132,238 people who have side effects when taking Alprazolam from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Coma scale abnormal?

Coma scale abnormal is found to be associated with 265 drugs and 359 conditions by eHealthMe. Check the latest studies of Coma scale abnormal.

On Jul, 15, 2026

132,238 people reported to have side effects when taking Alprazolam.
Among them, 78 people (0.06%) have Coma scale abnormal.

Could Alprazolam cause Coma scale abnormal?

Among these 78 people:

How long have people been on Alprazolam when they have Coma scale abnormal? *

What is the gender of people who have Coma scale abnormal when taking Alprazolam? *

female: 72.46 %
male: 27.54 %

What is the age of people who have Coma scale abnormal when taking Alprazolam? *

What are other drugs people take besides Alprazolam? *

What are other side effects people have besides Coma scale abnormal? *

Overdose: 25 people, 32.05%
Depressed Level Of Consciousness: 22 people, 28.21%
Intentional Self-Injury: 17 people, 21.79%
Loss Of Consciousness: 15 people, 19.23%
Hypotension (abnormally low blood pressure): 13 people, 16.67%
Sopor (sleep): 12 people, 15.38%
Anticholinergic Syndrome (absolute or relative reduction in cholinergic activity in the central nervous system): 11 people, 14.10%
Nausea And Vomiting: 10 people, 12.82%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 9 people, 11.54%
Agitation (state of anxiety or nervous excitement): 8 people, 10.26%

What are the existing conditions these people have? *

Depression: 14 people, 17.95%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 11 people, 14.10%
Suicide Attempt: 3 people, 3.85%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 1.28%
Self Injurious Behavior: 1 person, 1.28%
Pain: 1 person, 1.28%
Depressive Symptom: 1 person, 1.28%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 1.28%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and have Coma scale abnormal?

- Check whether Coma scale abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alprazolam:

Alprazolam (134,864 reports)

Browse all side effects of Alprazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Coma scale abnormal:

Coma scale abnormal (265 drugs)

Browse all the conditions that are associated with Coma scale abnormal:

Coma scale abnormal (359 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprazolam (the active ingredients of Alprazolam) and Alprazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.